World Journal of Gastroenterology

Article	Citations
Carcinoid syndrome caused by a pulmonary carcinoid mimics intestinal manifestations of ulcerative colitis: A case report	338
Very early onset perinatal constipation: Can it be cow’s milk protein allergy?	325
Comment on “Prognostic value of preoperative enhanced computed tomography as a quantitative imaging biomarker in pancreatic cancer”	312
Molecular mechanisms implicated in SARS-CoV-2 liver tropism	227
Return to work in young and middle-aged colorectal cancer survivors: Factors influencing self-efficacy, fear, resilience, and financial toxicity	211
Endoscopic intramural cystogastrostomy for treatment of peripancreatic fluid collection: A viewpoint from a surgeon	168
Knowledge and attitudes towards the use of histological assessments in ulcerative colitis by gastroenterologists vs pathologists	143
Unresolved conundrum of the role of physical activity in irritable bowel disease: What next?	139
Link between pharyngeal acid reflux episodes and the effectiveness of proton pump inhibitor therapy	126
Improving early diagnosis of multiple endocrine neoplasia type 1 by assessing the gastrointestinal symptoms, hypercalcemia, and elevated serum gastrin	121
Three-dimensional location approach with silk thread guided hepatectomy for liver tumor	114
Fecal microbiota transplantation: A promising treatment strategy for chronic liver disease	101
Factors other than fibrosis that increase measured shear wave velocity	100
Beyond biomarkers: An integrated traditional Chinese medicine-machine learning approach predicts hepatic steatosis in high metabolic risk populations	99
Gastric pentadecapeptide BPC 157 in cytoprotection to resolve major vessel occlusion disturbances, ischemia-reperfusion injury following Pringle maneuver, and Budd-Chiari syndrome	99
Parasites of the liver: A global problem?	99
Development and validation of a nomogram for preoperative prediction of tumor deposits in colorectal cancer	96
Role of gadoxetic acid-enhanced liver magnetic resonance imaging in the evaluation of hepatocellular carcinoma after locoregional treatment	93
Inflammatory bowel diseases patients suffer from significant low levels and barriers to physical activity: The “BE-FIT-IBD” study	86
Contributions of the receptor for advanced glycation end products axis activation in gastric cancer	84
Liver parasites: A global endemic and journey from infestation to intervention	75
Establishment and validation of an adherence prediction system for lifestyle interventions in non-alcoholic fatty liver disease	74
Intestinal flora was associated with occurrence risk of chronic non-communicable diseases	73
Prostaglandin F2α synthase promotes oxaliplatin resistance in colorectal cancer through prostaglandin F2α-dependent and F2α-independent mechanism	69
New treatment for gastroesophageal reflux disease: Traditional medicine, Xiaochaihu decoction	66

Systemic treatment for metastatic colorectal cancer	65
Dynamics of cytokines predicts risk of hepatocellular carcinoma among chronic hepatitis C patients after viral eradication	63
Gastroesophageal reflux following peroral endoscopic myotomy for achalasia: Bumps in the road to success	62
Machine learning algorithms reveal gut microbiota signatures associated with chronic hepatitis B-related hepatic fibrosis	62
Downregulation of TNFR2 decreases survival gene expression, promotes apoptosis and affects the cell cycle of gastric cancer cells	61
Gastroenterology in the age of artificial intelligence: Bridging technology and clinical practice	61
Divergent trajectories of lean vs obese non-alcoholic steatohepatitis patients from listing to post-transplant: A retrospective cohort study	60
Study of the roles of caspase-3 and nuclear factor kappa B in myenteric neurons in a P2X7 receptor knockout mouse model of ulcerative colitis	59
Validation of prognostic scores for predicting acute liver failure and in-hospital death in patients with dengue-induced severe hepatitis	59
Gastroesophageal reflux after per-oral endoscopic myotomy: Management literature	58
Influence of blood transfusion on postoperative inflammation, stress markers, and prognosis in patients with gastric cancer	57
Altered gut microbiota patterns in COVID-19: Markers for inflammation and disease severity	57
Examining dietary interventions in Crohn’s disease	55
Involvement of nitrergic neurons in colonic motility in a rat model of ulcerative colitis	55
Amoxicillin high-dose dual therapy for Helicobacter pylori primary eradication: Proton pump inhibitor and potassium-competitive acid blocker, which’s better?	55
Risk factors and a predictive nomogram for lymph node metastasis in superficial esophageal squamous cell carcinoma	54
Colorectal motility patterns and psychiatric traits in functional constipation and constipation-predominant irritable bowel syndrome: A study from China	54
Machine learning identifies the risk of complications after laparoscopic radical gastrectomy for gastric cancer	54
Primary hyperparathyroidism-induced acute pancreatitis in pregnancy: A systematic review with a diagnostic-treatment algorithm	53
Nonlinear association between estimated plasma volume status and acute kidney injury in acute pancreatitis patients	53
Prognostic impact and reasons for variability by tumor location in gastric cancer	53
Fibroblast growth factor 15, induced by elevated bile acids, mediates the improvement of hepatic glucose metabolism after sleeve gastrectomy	52
Autoimmune liver diseases in systemic rheumatic diseases	52
Bridging the gap: Unveiling the crisis of physical inactivity in inflammatory bowel diseases	51
Suberoylanilide hydroxamic acid upregulates reticulophagy receptor expression and promotes cell death in hepatocellular carcinoma cells	51
GLP-1, GIP/GLP-1, and GCGR/GLP-1 receptor agonists: Novel therapeutic agents for metabolic dysfunction-associated steatohepatitis	51
Relationship between clinical remission of perianal fistulas in Crohn’s disease and serum adalimumab concentrations: A multi-center cross-sectional study	50
Leveraging machine learning for early recurrence prediction in hepatocellular carcinoma: A step towards precision medicine	49
MicroRNAs: A novel signature in the metastasis of esophageal squamous cell carcinoma	49
Frailty in end-stage liver disease: Understanding pathophysiology, tools for assessment, and strategies for management	48
Back to the drawing board: Overview of the next generation of combination therapy for inflammatory bowel disease	48
BanXiaXieXin decoction treating gastritis mice with drug-resistant Helicobacter pylori and its mechanism	48
Urea breath test for Helicobacter pylori infection in adult dyspeptic patients: A meta-analysis of diagnostic test accuracy	48
Impaired coagulation, liver dysfunction and COVID-19: Discovering an intriguing relationship	46
Modern drug discovery for inflammatory bowel disease: The role of computational methods	46
New objective scoring system to clinically assess fecal incontinence	45
Artificial intelligence system for the detection of Barrett’s esophagus	45
Perianal fistulizing Crohn’s disease: Mechanisms and treatment options focusing on cellular therapy	42
Exploring the oncogenic potential of SARS-CoV-2 in the gastrointestinal tract	42
Diagnostic role of transient elastography in patients with autoimmune liver diseases: A systematic review and meta-analysis	41
Role of one-step nucleic acid amplification in colorectal cancer lymph node metastases detection	41
Liquid biopsy for gastric cancer: Techniques, applications, and future directions	41
SARS-CoV-2 infection in people with pre-existing liver disease: Further research is warranted	40
Hepatitis B virus infection in patients with Wilson disease: A large retrospective study	40
Artificial intelligence and inflammatory bowel disease: Where are we going?	40
Anoctamin 5 regulates the cell cycle and affects prognosis in gastric cancer	40
Outcomes of ABO-incompatible liver transplantation in end-stage liver disease patients co-infected with hepatitis B and human immunodeficiency virus	39
Prediction of moderately severe and severe acute pancreatitis in pregnancy: Several issues	39
Advances and challenges in peroral endoscopic myotomy: Safety, precision, and post-procedure management	39
Ras-related protein Rab24 plays a predictive role in hepatocellular carcinoma and enhanced tumor proliferation	39

Comparison of clinical characteristics and prognostic factors in two site-specific categories of ampullary cancer	38
Anti-RPL30 as a novel biomarker for enhanced diagnosis of autoantibody-negative primary biliary cholangitis	38
Development and validation of a predictive model for the pathological upgrading of gastric low-grade intraepithelial neoplasia	38
Correction to "CMA down-regulates p53 expression through degradation of HMGB1 protein to inhibit irradiation-triggered apoptosis in hepatocellular carcinoma"	38
Elafibranor: A promising therapeutic approach for liver fibrosis and gut barrier dysfunction in alcohol-associated liver disease	37
Evaluation of the efficacy and safety of endoscopic band ligation in the treatment of bleeding from mild to moderate gastric varices type 1	37
Cellular strategies to induce immune tolerance after liver transplantation: Clinical perspectives	37
Survival benefit of younger gastric cancer patients in China and the United States: A comparative study	37
Second United Arab Emirates consensus guidance on the diagnosis and management of inflammatory bowel disease	37
Hepatitis B and circadian rhythm of the liver	36
Bicuculline ameliorates metabolic dysfunction-associated steatotic liver disease by inhibiting the nuclear factor-kappa B pathway and reducing lipid accumulation	36
Impact of chronic liver disease on SARS-CoV-2 infection outcomes: Roles of stage, etiology and vaccination	35
Esophageal melanosis: Two case reports and review of literature	35
Current approaches to the management of jejunal variceal bleeding at the site of hepaticojejunostomy after pancreaticoduodenectomy	35
Development of a deep learning model for guiding treatment decisions of acute variceal bleeding in patients with cirrhosis	35
Depression weights in patients with gastric cancer: Bibliometric analysis as a weapon to chart the future of research	35
Role of albumin-bilirubin score in non-malignant liver disease	35
Assessing deep learning models for multi-class upper endoscopic disease segmentation: A comprehensive comparative study	35
Photo-activated microtubule targeting drugs: Advancing therapies for colorectal cancer	34
Stage at diagnosis of colorectal cancer through diagnostic route: Who should be screened?	34
Vonoprazan-amoxicillin dual regimen with Saccharomyces boulardii as a rescue therapy for Helicobacter pylori: Current perspectives and implications	34
Serum metabolic profiling of targeted bile acids reveals potentially novel biomarkers for primary biliary cholangitis and autoimmune hepatitis	34
Effectiveness and safety of tenofovir amibufenamide in chronic hepatitis B patients	33
Dopamine receptor D1-mediated suppression of liver fibrosis via Hippo/Yes-associated protein 1 signaling in levodopa treatment	33
Antihepatoma peptide, scolopentide, derived from the centipede scolopendra subspinipes mutilans	33
Pediatric stricturing Crohn's disease	33
Clinical manifestations, diagnosis and long-term prognosis of adult autoimmune enteropathy: Experience from Peking Union Medical College Hospital	33
Timing of biliary decompression for acute cholangitis	32
Emerging role of non-invasive and liquid biopsy biomarkers in pancreatic cancer	32
Neutrophil extracellular traps participate in the development of cancer-associated thrombosis in patients with gastric cancer	32
18β-glycyrrhetinic acid promotes gastric cancer cell autophagy and inhibits proliferation by regulating miR-328-3p/signal transducer and activator of transcription 3	32
Pregnancy and fetal outcomes of chronic hepatitis C mothers with viremia in China	32
Comprehensive microbial and clinical profiling of functional constipation: A stratified comparative study of age and constipation subtype	32
Real-time continuous image guidance for endoscopic retrograde cholangiopancreatography based on 3D/2D registration and respiratory compensation	32
Prognostic role of intestinal ultrasound in Crohn’s disease	31
Impact of baseline body mass index on the long-term prognosis of advanced hepatocellular carcinoma treated with immunotherapy	31
Distinct gut microbiomes in Thai patients with colorectal polyps	31
Mixed neuroendocrine–nonneuroendocrine neoplasms of the gastrointestinal system: An update	31
Orosomucoid in liver diseases	30
Emerging role of exosomes in ulcerative colitis: Targeting NOD-like receptor family pyrin domain containing 3 inflammasome	30
Bibliometrics analysis based on the Web of Science: Current trends and perspective of gastric organoid during 2010-2023	30
Glucagon-like peptide 1 agonists are potentially useful drugs for treating metabolic dysfunction-associated steatotic liver disease	29
Comprehensive approach to esophageal variceal bleeding: From prevention to treatment	29
Unveiling the anticancer effect of traditional Chinese herbal medicine	29
Epidemiology of small intestinal bacterial overgrowth	29
High incidence combination of multiple primary malignant tumors of the digestive system	29
Endothelial cells and blood vessels are major targets for COVID-19-induced tissue injury and spreading to various organs	29
Gut microbiota and female health	29
Vonoprazan and proton pump inhibitors: Which is superior for Helicobacter pylori eradication?	29
Liver biopsy in the post-hepatitis C virus era in Japan	28
Lipocalin-2 and intestinal diseases	28
Intracellular alpha-fetoprotein mitigates hepatocyte apoptosis and necroptosis by inhibiting endoplasmic reticulum stress	28
Angiotensin-converting enzyme 2 improves liver fibrosis in mice by regulating autophagy of hepatic stellate cells	28
Chinese patent medicine: Opening new perspectives for treatment of post-endoscopic submucosal dissection esophageal stricture in esophageal cancer patients	28
Triglyceride-glucose index as a prognostic indicator in advanced gastric cancer: Insights and future research	27
Immune and metabolic cross-links in the pathogenesis of comorbid non-alcoholic fatty liver disease	27
Transanal eco-Doppler evaluation after hemorrhoidal artery embolization	27
Targeting therapy for hepatocellular carcinoma by delivering microRNAs as exosomal cargo	27
Optimal timing of biliary drainage based on the severity of acute cholangitis: A single-center retrospective cohort study	27
Comparative evaluation of three traditional herbal formulas on gastrointestinal motility in a mouse model of cold stress-induced dyspepsia	27
HP0953 hypothetical protein overexpresses and localization as virulence factor from Helicobacter pylori during infection to gastric epithelium cells	27
Postoperative outcomes and recurrence patterns of intermediate-stage hepatocellular carcinoma dictated by the sum of tumor size and number	27
Link between childhood obesity and gut microbiota	27
Ligation-assisted endoscopic submucosal resection following unroofing technique for small esophageal subepithelial lesions originating from the muscularis propria	26
Efficacy and safety of different doses of dexmedetomidine on gastrointestinal function recovery after laparoscopic colorectal surgery	26
Revaluation of Helicobacter pylori's role in esophageal carcinoma: A call for comprehensive research	26
Unraveling the therapeutic potential of Calculus Bovis in liver cancer: A novel step for targeted cancer treatment	26
Current status of magnetic resonance imaging radiomics in hepatocellular carcinoma: A quantitative review with Radiomics Quality Score	26
Idiopathic retroperitoneal fibrosis arising from peritoneal space: A case report and review of literature	26
Challenges involved in the application of artificial intelligence in gastroenterology: The race is on!	25
International patterns in incidence and mortality trends of pancreatic cancer in the last three decades: A joinpoint regression analysis	25
Susceptibility patterns and virulence genotypes of Helicobacter pylori affecting eradication therapy outcomes among Egyptian patients with gastroduodenal diseases	25
Outreach onsite treatment with a simplified pangenotypic direct-acting anti-viral regimen for hepatitis C virus micro-elimination in a prison	25
Interaction between diet and genetics in patients with inflammatory bowel disease	25
Prolonged hyperthermic intraperitoneal chemotherapy duration with 90 minutes cisplatin might increase overall survival in gastric cancer patients with peritoneal metastases	25
Fusobacterium nucleatum-induced imbalance in microbiome-derived butyric acid levels promotes the occurrence and development of colorectal cancer	25
Diagnostic tools for fecal incontinence: Scoring systems are the crucial first step	25
Prevalence and clinical impact of sarcopenia in liver transplant recipients: A meta-analysis	25
Development of a nomogram for predicting liver transplantation prognosis in hepatocellular carcinoma	25
Close relationship between mediators of inflammation and pancreatic cancer: Our experience	25

Risk elements and diagnostic indicators for asymptomatic immune checkpoint inhibitor-associated myocarditis in esophageal cancer	25
Hepatitis B core antigen modulates exosomal miR-135a to target vesicle-associated membrane protein 2 promoting chemoresistance in hepatocellular carcinoma	25
Anabolic androgenic steroid-induced liver injury: An update	25
Machine perfusion in liver transplantation: A step forward, but still on the runway	25
Multiple subcellular localizations and functions of protein kinase Cδ in liver cancer	24
Liver histopathological lesions is severe in patients with normal alanine transaminase and low to moderate hepatitis B virus DNA replication	24
Exploring the regulatory mechanism of tRNA-derived fragments 36 in acute pancreatitis based on small RNA sequencing and experiments	24
Hepatocardiorenal syndrome in liver cirrhosis: Recognition of a new entity?	24
Important role of lymphovascular and perineural invasion in prognosis of colorectal cancer patients with N1c disease	24
Enteric nervous system and inflammatory bowel diseases: Correlated impacts and therapeutic approaches through the P2X7 receptor	24
May ChatGPT be a tool producing medical information for common inflammatory bowel disease patients’ questions? An evidence-controlled analysis	24
Interplay of gut microbiota, glucagon-like peptide receptor agonists, and nutrition: New frontiers in metabolic dysfunction-associated steatotic liver disease therapy	24
Hepatic pseudolesions caused by alterations in intrahepatic hemodynamics	24
Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies in the targeted therapy era	24
Pro and anti-inflammatory diets as strong epigenetic factors in inflammatory bowel disease	24
Return to work in young and middle-aged colorectal cancer survivors: Factors influencing self-efficacy, fear, resilience, and financial toxicity	24
Future prospect of “Gut microbiome composition can predict the response to nivolumab in advanced hepatocellular carcinoma patients”	23
Radiomics for the detection of microvascular invasion in hepatocellular carcinoma	23
Gut microbiota plays a key role in the development of colorectal cancer	23
Insights from exploring the interrelated dynamics of gallstone disease, non-alcoholic fatty liver disease, and kidney stone disease	23
Current status and progress in laparoscopic surgery for gallbladder carcinoma	23
Acute liver injury in COVID-19 patients hospitalized in the intensive care unit: Narrative review	23
Clinical outcomes of lenvatinib plus transarterial chemoembolization with or without programmed death receptor-1 inhibitors in unresectable hepatocellular carcinoma	23
Irreversible electroporation for the management of pancreatic cancer: Current data and future directions	23
Cytotoxic synergism of Clostridioides difficile toxin B with proinflammatory cytokines in subjects with inflammatory bowel diseases	23
Predicting disease progression in cirrhotic patients after transjugular intrahepatic portosystemic shunt implantation: A sex-stratified analysis	22
Global research trends in the field of liver cirrhosis from 2011 to 2020: A visualised and bibliometric study	22
Paneth cells inhibit intestinal stem cell proliferation through the bone morphogenic protein 7 pathway under rotavirus-mediated intestinal injury	22
Upregulated adenosine 2A receptor accelerates post-infectious irritable bowel syndrome by promoting CD4+ T cells’ T helper 17 polarization	22
Application of Wuling powder in the treatment of ulcerative colitis complicated by depression as a new therapy principle	22
Saccharomyces cerevisiae prevents postoperative recurrence of Crohn's disease modeled by ileocecal resection in HLA-B27 transgenic rats	22
Exploring non-curative endoscopic submucosal dissection: Current treatment optimization and future indication expansion	22
Unlocking the potential of Calculus bovis: A breakthrough in liver cancer treatment via Wnt/β-catenin pathway modulation	22
Genetic intersection of human leukocyte antigen-DP/DQ and hepatitis B virus-related liver disease: Insights from a multi-clustering study	22
Linear endoscopic ultrasound: Current uses and future perspectives in mediastinal examination	22
Abnormally activated wingless/integrated signaling modulates tumor-associated macrophage polarization and potentially promotes hepatocarcinoma cell growth	22
Dual-targeted treatment for inflammatory bowel disease: Whether fecal microbiota transplantation can be an important part of it	22
Locked nucleic acid real-time polymerase chain reaction method identifying two polymorphisms of hepatitis B virus genotype C2 infections, rt269L and rt269I	22
Hypoxia inducible factor 1α promotes interleukin-1 receptor antagonist expression during hepatic ischemia-reperfusion injury	22
Trichostatin A augments cell migration and epithelial-mesenchymal transition in esophageal squamous cell carcinoma through BRD4/c-Myc endoplasmic reticulum-stress pathway	21
Successful treatment of an enormous rectal mucosa-associated lymphoid tissue lymphoma by endoscopic full-thickness resection: A case report	21
Sequence of events leading to primary biliary cholangitis	21
From bench to bedside: Advancements in patient-derived xenografts for predicting therapy outcomes in colorectal cancer	21
Regulation of transforming growth factor-β signaling as a therapeutic approach to treating colorectal cancer	21
Prevalence of metabolic dysfunction-associated fatty liver disease among health check-up attendees: A retrospective study conducted in Vietnam	21
Age- and gender-specific dynamics and next-generation reference intervals for pepsinogen in northern China	21
Gut microbiota predicts the diagnosis of celiac disease in Saudi children	21
Brown slits for colorectal adenoma crypts on conventional magnifying endoscopy with narrow band imaging using the X1 system	21
Gastric cancer incidence based on endoscopic Kyoto classification of gastritis	21
Gut microbiome-specific nanoparticle-based therapeutics for liver diseases	21
Expanding indications for chronic hepatitis B treatment: Is it really desirable to treat everyone?	21
Nuclear factor erythroid 2-related factor 2-mediated signaling and metabolic associated fatty liver disease	21
Effectiveness, safety, and drug sustainability of biologics in elderly patients with inflammatory bowel disease: A retrospective study	21
Hepatic arterial infusion chemotherapy with anti-angiogenesis agents and immune checkpoint inhibitiors for unresectable hepatocellular carcinoma and meta-analysis	21
Advances in understanding and managing celiac disease: Pathophysiology and treatment strategies	21
Covering the biopsy hole check valve with “enzymolysis gauze” reduces bacterial contamination in the endoscopy room	21
Obesity paradox role in the immunosuppressive treatment of hepatocellular carcinoma	21
Loss of monopolar spindle-binding protein 3B expression promotes colorectal cancer malignant behaviors by activation of target of rapamycin kinase/autophagy signaling	21
Prognostic significance of hemoglobin, albumin, lymphocyte, platelet in gastrointestinal stromal tumors: A propensity matched retrospective cohort study	20
F-box only protein 2 exacerbates non-alcoholic fatty liver disease by targeting the hydroxyl CoA dehydrogenase alpha subunit	20
Multi-clustering study on the association between human leukocyte antigen-DP-DQ and hepatitis B virus-related hepatocellular carcinoma and cirrhosis in Viet Nam	20
Non-alcoholic fatty liver disease and COVID-19: Harmless companions or disease intensifier?	20
Mechanisms of ductular reaction in non-alcoholic steatohepatitis	20
Nonalcoholic fatty liver disease following laparoscopic duodenum-preserving pancreatic total head resection vs laparoscopic pancreaticoduodenectomy: A retrospective cohort study	20
Syngeneic implantation of mouse hepatic progenitor cell-derived three-dimensional liver tissue with dense collagen fibrils	20
Clinical utility of two-dimensional shear-wave elastography in monitoring disease course in autoimmune hepatitis-primary biliary cholangitis overlap syndrome	20
Infliximab vs adalimumab: Points to consider when selecting anti-tumor necrosis factor agents in pediatric patients with Crohn’s disease	20
Novel index for the prediction of significant liver fibrosis and cirrhosis in chronic hepatitis B patients in China	20
N6-methyladenosine-modified long non-coding RNA KIF9-AS1 promotes stemness and sorafenib resistance in hepatocellular carcinoma by upregulating SHOX2 expression	20
Critical assessment of the reported bidirectional associations between gallstone, non-alcoholic fatty liver, and kidney stone diseases	20
Automatic detection of small bowel lesions with different bleeding risks based on deep learning models	20
Computed tomography-based radiomics combined with machine learning allows differentiation between primary intestinal lymphoma and Crohn's disease	20
Angiotensin-converting enzyme 2 alleviates liver fibrosis through the renin-angiotensin system	20
Clinical value of the Toronto inflammatory bowel disease global endoscopic reporting score in ulcerative colitis	20
Comments on “Effect of type 2 diabetes mellitus in the prognosis of acute-on-chronic liver failure patients in China”	20
Prognostic factors of recurrent intrahepatic cholangiocarcinoma after hepatectomy: A retrospective study	20
Harnessing the power of Calculus bovis: Anti-cancer properties and Wnt pathway modulation in hepatocellular carcinoma	20
Green tea polyphenols alleviate di-(2-ethylhexyl) phthalate-induced liver injury in mice	19
Gut dysbiosis and small intestinal bacterial overgrowth as independent forms of gut microbiota disorders in cirrhosis	19
Rectal neuroendocrine tumors: Can we predict their behavior?	19
Age-specific causes of upper gastrointestinal bleeding in children	19
COVID-19 and liver injury in individuals with obesity	19
Mean nocturnal baseline impedance in gastro-esophageal reflux disease diagnosis: Should we strictly follow the Lyon 2 Consensus?	19
Gastrointestinal microbiota: A predictor of COVID-19 severity?	19
Diagnosis, treatment, and current concepts in the endoscopic management of gastroenteropancreatic neuroendocrine neoplasms	19
Is Helicobacter pylori infection protective against esophageal cancer?	19
Correction to: Hepatocellular carcinoma xenograft supports HCV replication: A mouse model for evaluating antivirals	19
Prognostic value of signet-ring cell carcinoma proportion in undifferentiated gastric cancer: Implications for endoscopic treatment decisions	19
Clinical features, diagnosis, and treatment of Peutz-Jeghers syndrome: Experience with 566 Chinese cases	19
Validation model of fibrosis-8 index score to predict significant fibrosis among patients with nonalcoholic fatty liver disease	19
Helicobacter pylori infection is linked to metabolic dysfunction and associated steatotic liver disease: A large cross-sectional study	19
Endoscopic treatment of scarred polyps with a non-thermal device (Endorotor): A review of the literature‎	19
Novel chromogenic medium-based method for the rapid detection of Helicobacter pylori drug resistance	19
Myeloperoxidase, extracellular DNA and neutrophil extracellular trap formation in the animal models of metabolic dysfunction-associated steatotic liver disease	19
Role of magnifying narrow-band imaging endoscopy for diagnosis of Helicobacter pylori infection and gastric precancerous conditions: Few issues	19